Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02732210 · ClinicalTrials.gov registry record
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
A clinical trial, sponsored by Amgen.
- Completed
- Registry status
- 935
- Enrollment target
NCT02732210 is a clinical trial that has completed, run by Amgen. The registered enrollment target is 935 participants.
The verdict
NCT02732210 has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- 935 participants
- Enrollment target
Study Summary
The objective of this study was to describe persistence with Prolia® 60 mg administered subcutaneously (SC) every 6 months (Q6M) at 12 and 24 months.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 935 participants |
| Start Date | 2011-07-06 |
| Est. Completion | 2014-04-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02732210
The ClinicalTrials.gov registry entry for NCT02732210 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 935 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02732210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02732210 about?
NCT02732210 is a clinical study titled "Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis". The objective of this study was to describe persistence with Prolia® 60 mg administered subcutaneously (SC) every 6 months (Q6M) at 12 and 24 months.
What is the current status of trial NCT02732210?
This trial is currently completed. The enrollment target is 935 participants. The study started on 2011-07-06. Estimated completion is 2014-04-14.
Who is sponsoring clinical trial NCT02732210?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.